Entry ID | Original Release date | Data summary | Entry Title | Citation Title | Authors |
---|---|---|---|---|---|
26513 | 2015-02-24 | Heteronuclear NOE Values: 1 set T1 Relaxation Values: 1 set T2 Relaxation Values: 1 set Order Parameters: 1 set |
The Apo-structure of the Low Molecular Weight Protein-tyrosine Phosphatase A (MptpA) from Mycobacterium tuberculosis Allows for Better Target-specific Drug Development | The Apo-structure of the Low Molecular Weight Protein-tyrosine Phosphatase A (MptpA) from Mycobacterium tuberculosis Allows for Better Target-specific Drug Development | Christian Richter, Frank Lohr, Harald Schwalbe, Hendrik Jonker, Krishna Saxena, Sridhar Sreeramulu, Tanja Stehle |
19388 | 2013-08-28 | Heteronuclear NOE Values: 1 set T1 Relaxation Values: 1 set T2 Relaxation Values: 1 set Order Parameters: 1 set |
The Apo-structure of the Low Molecular Weight Protein-tyrosine Phosphatase A (MptpA) from Mycobacterium tuberculosis Allows for Better Target-specific Drug Development | The Apo-structure of the Low Molecular Weight Protein-tyrosine Phosphatase A (MptpA) from Mycobacterium tuberculosis Allows for Better Target-specific Drug Development | Christian Richter, Frank Lohr, Harold Schwalbe, Hendrik R A Jonker, Krishna Saxena, Sridhar Sreeramulu, Tanja Stehle |
19361 | 2013-08-12 | Heteronuclear NOE Values: 1 set T1 Relaxation Values: 1 set T2 Relaxation Values: 1 set |
The Apo-structure of the Low Molecular Weight Protein-tyrosine Phosphatase A (MptpA) from Mycobacterium tuberculosis Allows for Better Target-specific Drug Development | The Apo-structure of the Low Molecular Weight Protein-tyrosine Phosphatase A (MptpA) from Mycobacterium tuberculosis Allows for Better Target-specific Drug Development | Christian Richter, Frank Lohr, Harold Schwalbe, Hendrik R A Jonker, Krishna Saxena, Sridhar Sreeramulu, Tanja Stehle |
18533 | 2012-08-13 | Chemical Shifts: 1 set |
NMR solution structure of apo-MptpA | The apo-structure of the low-molecular-weight protein tyrosine phosphatase A (MptpA) from Mycobacterium tuberculosis allows for better target-specific drug development | Christian Richter, Frank Loehr, Harald Schwalbe, Hendrik RA Jonker, Krishna Saxena, Sridhar Sreeramulu, Tanja Stehle |